Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
77 hedge funds and large institutions have $113M invested in Kindred Biosciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 13 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
5% less capital invested
Capital invested by funds: $118M → $113M (-$5.61M)
7% less funds holding
Funds holding: 83 → 77 (-6)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.11M |
| 2 |
Renaissance Technologies
New York
|
+$699K |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$634K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$385K |
| 5 |
Morgan Stanley
New York
|
+$345K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.15M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$404K |
| 3 |
HP
Hound Partners
New York
|
-$359K |
| 4 |
Squarepoint
New York
|
-$328K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$235K |
KIN Hedge Fund Activity: Q3 2020 in Review
77 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2020, worth a combined $113M — down 4.7% from $118M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of KIN and 8 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 27 added.
The largest buyer was Acadian Asset Management, adding an estimated $1.11M. The largest seller was Millennium Management, cutting an estimated $3.15M.
- 77 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2020, down from 83 in Q2 2020.
- Funds reported $113M of Kindred Biosciences, Inc. stock for Q3 2020, down 4.7% quarter-over-quarter.
- 8 funds opened new Kindred Biosciences, Inc. positions in Q3 2020 and 13 closed out, a net change of -5 holders.
- The largest Kindred Biosciences, Inc. buyer in Q3 2020 was Acadian Asset Management, an estimated $1.11M added.
- The largest Kindred Biosciences, Inc. seller in Q3 2020 was Millennium Management, an estimated $3.15M sold.
Based on aggregated 13F filings for Q3 2020.